Tapping into combination pills for HIV

Abstract

Joint venture between GlaxoSmithKline and Pfizer in HIV illustrates opportunities to develop combination pills to challenge current market leaders. 
DOI: 10.1038/nrd2917

1 Figure or Table

Topics

  • Presentations referencing similar topics